Re: Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma

被引：0
作者：
Chang, Sam S.
机构：
来源：
JOURNAL OF UROLOGY | 2022年 / 207卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：228 / 228
页数：1
相关论文
共 50 条
  • [31] Drug approval: Enfortumab vedotin-advanced urothelial carcinoma (which have previously received platinum-containing chemotherapy and immunotherapy)
    Matte, Paul
    Campedel, Luca
    BULLETIN DU CANCER, 2022, 109 (7-8) : 738 - 740
  • [32] Primary results of EV-301: A phase III trial of enfortumab vedotin versus chemotherapy in patients with previously treated locally advanced or metastatic urothelial carcinoma.
    Powles, Thomas
    Rosenberg, Jonathan E.
    Sonpavde, Guru
    Loriot, Yohann
    Duran, Ignacio
    Lee, Jae-Lyun
    Matsubara, Nobuaki
    Vulsteke, Christof
    Wu Chunzhang
    Campbell, Mary S.
    Matsangou, Maria
    Petrylak, Daniel Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [33] A phase I study of enfortumab vedotin in Japanese patients with locally advanced or metastatic urothelial carcinoma
    Takahashi, Shunji
    Uemura, Motohide
    Kimura, Tomokazu
    Kawasaki, Yoshihide
    Takamoto, Atsushi
    Yamaguchi, Akito
    Melhem-Bertrandt, Amal
    Gartner, Elaina M.
    Inoue, Takashi
    Akazawa, Rio
    Kadokura, Takeshi
    Tanikawa, Toshiki
    INVESTIGATIONAL NEW DRUGS, 2020, 38 (04) : 1056 - 1066
  • [34] Current and Emerging Treatments for Urothelial Carcinoma: A Focus on Enfortumab Vedotin
    Shafique, Muhammad Ashir
    Haseeb, Abdul
    Siddiq, Mohammad Arham
    Mussarat, Abdullah
    Rangwala, Hussain Sohail
    Mustafa, Muhammad Saqlain
    CANCER MANAGEMENT AND RESEARCH, 2023, 15 : 699 - 706
  • [35] A phase I study of enfortumab vedotin in Japanese patients with locally advanced or metastatic urothelial carcinoma
    Shunji Takahashi
    Motohide Uemura
    Tomokazu Kimura
    Yoshihide Kawasaki
    Atsushi Takamoto
    Akito Yamaguchi
    Amal Melhem-Bertrandt
    Elaina M. Gartner
    Takashi Inoue
    Rio Akazawa
    Takeshi Kadokura
    Toshiki Tanikawa
    Investigational New Drugs, 2020, 38 : 1056 - 1066
  • [36] Clinical Outcomes of Enfortumab Vedotin in Advanced Urothelial Carcinoma With Prior Avelumab Versus Pembrolizumab Therapy
    Minato, Akinori
    Furubayashi, Nobuki
    Tomoda, Toshihisa
    Masaoka, Hiroyuki
    Song, Yoohyun
    Hori, Yoshifumi
    Kiyoshima, Keijiro
    Negishi, Takahito
    Kuroiwa, Kentaro
    Seki, Narihito
    Tomisaki, Ikko
    Nakamura, Motonobu
    Harada, Kenichi
    Fujimoto, Naohiro
    ANTICANCER RESEARCH, 2024, 44 (08) : 3419 - 3426
  • [37] Phase II Trial of Enfortumab Vedotin in Patients With Previously Treated Advanced Head and Neck Cancer
    Swiecicki, Paul L.
    Yilmaz, Emrullah
    Rosenberg, Ari Joseph
    Fujisawa, Takao
    Bruce, Justine Yang
    Meng, Changting
    Wozniak, Michele
    Zhao, Yongyun
    Mihm, Michael
    Kaplan, Jason
    Gorla, Seema
    Geiger, Jessica L.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (05) : 578 - 588
  • [38] Evaluating outcomes of sacituzumab govitecan (SG) in patients with urothelial cancer (UC), previously treated with enfortumab vedotin (EV)
    Vlachou, Evangelia
    Johnson, Burles Avner
    Hahn, Noah M.
    Rourke, Kelli
    Mcconkey, David James
    Hoffman-Censits, Jean H.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 567 - 567
  • [39] Health-related Quality of Life in Patients with Previously Treated Advanced Urothelial Carcinoma from EV-301: A Phase 3 Trial of Enfortumab Vedotin Versus Chemotherapy
    Rosenberg, Jonathan E.
    Mamtani, Ronac
    Sonpavde, Guru P.
    Loriot, Yohann
    Duran, Ignacio
    Lee, Jae-Lyun
    Matsubara, Nobuaki
    Vulsteke, Christof
    Castellano, Daniel
    Sridhar, Srikala S.
    Pappot, Helle
    Gurney, Howard
    Bedke, Jens
    van der Heijden, Michiel S.
    Galli, Luca
    Keam, Bhumsuk
    Masumori, Naoya
    Meran, Johannes
    O'Donnell, Peter H.
    Park, Se Hoon
    Grande, Enrique
    Sengelov, Lisa
    Uemura, Hiroji
    Skaltsa, Konstantina
    Campbell, Mary
    Matsangou, Maria
    Wu, Chunzhang
    Hepp, Zsolt
    Mckay, Caroline
    Powles, Thomas
    Petrylak, Daniel P.
    EUROPEAN UROLOGY, 2024, 85 (06) : 574 - 585
  • [40] Administration of Enfortumab Vedotin after Immune-Checkpoint Inhibitor and the Prognosis in Japanese Metastatic Urothelial Carcinoma: A Large Database Study on Enfortumab Vedotin in Metastatic Urothelial Carcinoma
    Kawahara, Takashi
    Hasizume, Akihito
    Uemura, Koichi
    Yamaguchi, Katsuya
    Ito, Hiroki
    Takeshima, Teppei
    Hasumi, Hisashi
    Teranishi, Jun-ichi
    Ousaka, Kimito
    Makiyama, Kazuhide
    Uemura, Hiroji
    CANCERS, 2023, 15 (17)
12345